...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Top-line vs. Full Detailed Clinical Trial Results

Thank you. I agree $6 a share would be better than $3 by year end.

tada

Share
New Message
Please login to post a reply